Navigation Links
Vista Partners Initiates Coverage on Synvista Therapeutics, Inc. (AMEX: SYI)
Date:5/14/2008

LOS ANGELES, May 14 /PRNewswire/ -- Vista Partners announced today that it has initiated coverage on Synvista Therapeutics, Inc. (Amex: SYI). Ross Silver, Director of Research of Vista Partners stated, "Synvista is one of the best small cap investment opportunities investors will come across. The company is conducting four Phase 2 trials in multi-billion dollar markets. Additionally their Hp test which will serve a ~$100M market, could begin to produce revenues as early as next year. It is also important to note that Synvista is led by a top tier management team who has taken compounds from concept to approval, a feat few management teams in small cap biotech have achieved." To view the report on Synvista at no charge, please visit the Vista Partners website at http://www.vistap.com and click on the download research icon located on top right hand corner of the home page.

About Vista Partners:

Vista Partners provides independent, equity research to institutional and individual investors, with a focus on publicly traded small capitalization companies. With offices in Los Angeles and San Francisco, Vista Partners is one of the fastest growing independently owned equity research firms. Vista Partners professional staff has backgrounds in finance, corporate communications and investment banking. More information is available at http://www.vistap.com.

About Synvista Therapeutics, Inc.:

Synvista Therapeutics, Inc. is a product-based biotechnology company engaged in the development of diagnostic tests and drugs to identify and treat diabetic patients at high risk for the development of cardiovascular disease. The Company
'/>"/>

SOURCE Vista Partners
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Expiry of Hart-Scott-Rodino Waiting Period for JUVISTA(R) (Human TGF BETA 3)
2. OncoVista, Inc. Closes on $6.8 Million Financing and Acquires Control of a Public Shell Company
3. Synvista Therapeutics to Present at the BIO InvestorForum 2007
4. Synvista Therapeutics to be Featured on Wallst.net
5. Provista Awards Agreement to Spheris
6. Synvista Therapeutics to Develop Topical Formulation of ALT-2074 for the Treatment of Psoriasis
7. Synvista Therapeutics to Present at the 10th Annual BIO CEO & Investor Conference
8. Renovo Announces Results of Latest Phase 2 Studies of JUVISTA(R) (Human Recombinant TGFbeta3)
9. Vista Partners Updates Coverage on Inovio Biomedical Corporation (Amex: INO) With $3.52 Price Target
10. Synvista Therapeutics Highlights Newly Published Data Demonstrating the Value of Haptoglobin Genotype Testing In People with Diabetes
11. Bayer HealthCare Pharmaceuticals Introduces VistaTrak(TM) an Innovative Contrast Media Management System
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... December 23, 2014 “Preparative & ... HPLC, Flash), Consumables (Columns, Solvents, Buffers, Valves, Guages, ... & Agriculture) - Forecasts to 2019” provides a ... opportunities, current market trends, and strategies impacting the ... estimates and forecasts of the revenue and share ...
(Date:12/24/2014)... According to Ross Selinger, President of Selinger ... the national office market continues to be strong, driven by ... by the third quarter’s surprising 3.9% GDP, unemployment decreasing to ... have held inflation down and the Fed is keeping interest ... remaining soft. , This solid economic news is having a ...
(Date:12/24/2014)... , Dec. 23, 2014 China Biologic ... "Company"), a leading fully integrated plasma-based biopharmaceutical company ... that its majority-owned subsidiary, Shandong Taibang Biological Products ... certification from the China Food and Drug Administration ... facility. As previously disclosed in the Company,s public ...
(Date:12/24/2014)... NEW YORK , Dec. 23, 2014 ... pilot study of mazindol in children with attention deficit/hyperactivity ... in December 2014 . The paper, ... with attention deficit/hyperactivity disorder" ( Konofal et al, ... 1;8:2321-2332. eCollection 2014 ) shows that mazindol might ...
Breaking Biology Technology:Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 2Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 3Preparative and Process Chromatography Market is expected to reach $9 billion by 2019 - New Report by Marketsandmarkets 4ITRA Global Reports Long Island Is Out of Sync With The National Office Market 2ITRA Global Reports Long Island Is Out of Sync With The National Office Market 3China Biologic Receives GMP Certification for New Coagulation Factor Facility 2China Biologic Receives GMP Certification for New Coagulation Factor Facility 3Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 2Redefining ADHD: A New Approach & A Shift of Paradigm in ADHD Therapeutics 3
... Improve PCR product yield and specificity for ... Amplification Reactions with,Perfect Match PCR Enhancer ... Certain PCR amplification systems produce multiple product bands ... priming events, template secondary,structures, or suboptimal PCR conditions. ...
... use in transplantation studies , hNT BlueNeurons ... Michael McGrogan * Guadalupe Gonzalez * Waldemar Lernhardt ... hNT BlueNeurons express beta-galactosidase at high levels and,are ... stably transfected with a,lacZ gene expression vector. Because ...
... genomic targets up to 19 kb , Enhanced ... , Michael Borns Holly Hogrefe ,Stratagene , Improve ... by making simple modifications to PCR reaction,conditions. In this ... be amplified up to 19 kb in length. , ...
Cached Biology Technology:Optimizing pfuturbo DNA Polymerase Amplification Reactions with,Perfect Match PCR Enhancer 2Optimizing pfuturbo DNA Polymerase Amplification Reactions with,Perfect Match PCR Enhancer 3Optimizing pfuturbo DNA Polymerase Amplification Reactions with,Perfect Match PCR Enhancer 4Optimizing pfuturbo DNA Polymerase Amplification Reactions with,Perfect Match PCR Enhancer 5Optimizing pfuturbo DNA Polymerase Amplification Reactions with,Perfect Match PCR Enhancer 6hNT BlueNeurons Express b-Galactosidase at High ,Levels 2hNT BlueNeurons Express b-Galactosidase at High ,Levels 3hNT BlueNeurons Express b-Galactosidase at High ,Levels 4hNT BlueNeurons Express b-Galactosidase at High ,Levels 5Enhanced Amplification of Long Targets with PfuTurbo DNA,Polymerase 2Enhanced Amplification of Long Targets with PfuTurbo DNA,Polymerase 3
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... ( http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the ... 2015-2019" report to their offering. ... is the adoption of multimodal biometric systems. Multimodal ... an individual for verification and identification purposes. This ...
(Date:12/11/2014)... 10, 2014  Data Sciences International (DSI), the ... a new series of digital telemetry implants to ... M series, part of the PhysioTel™ Digital platform, ... possible physiologic data when incorporating functional endpoints into ... to toxicology studies has evolved from short ECG ...
(Date:12/10/2014)... N.C. , Dec. 9, 2014  Valencell, a ... it is seeing a staggering demand from its licensees ... the Company revealed, is not solely coming from fitness ... as well. "A wearable is only as ... result, accuracy is the ultimate driver in long-term mass ...
Breaking Biology News(10 mins):Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2New telemetry implants expected to change how large animal toxicology studies are conducted 2Wearable Technology Products Demand Highly Accurate Biometric Technology 2
... a bubble while washing the dishes and you,re likely ... the soapy sphere formed. A few years ago, researchers ... pioneered a method* using a microscopic fluidic (microfluidic) device ... called liposomes from phospholipids, the fat complexes that are ...
... released this week in The Lancet Infectious Diseases ... a bacterial infection that causes pneumonia, meningitis and sepsis ... disease, a blood disorder prevalent in African children that ... The study underscores the critical need for use of ...
... won two national Federal Laboratory Consortium awards for ... Cray Inc., and solar energy supplier Stirling Energy ... to present the Excellence in Technology Transfer Awards ... The consortium is a nationwide network of technology ...
Cached Biology News:NIST, Maryland researchers COMMAND a better class of liposomes 2Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 2Vaccines preventing pneumococcal disease protect African children with sickle-cell disease 3Sandia wins 2 national technology transfer awards for work with Cray, Stirling Energy Systems 2
... of a series of media originally developed at ... al. for the large scale propagation of cells ... primarily used for the growth and maintenance of ... of viruses in these cell lines. One of ...
... Trx•Tag™ Ek Adaptor encodes a T7 promoter, ... (rbs), ATG translation initation codon, and an ... a 109 aa sequence that encodes thioredoxin. ... to enhance solubility of many proteins that ...
... This CLS number is ... to easily match Cornings product ... yet, please order under the ... contact customer service for assistance. ...
A cost-effective serum for general cell growth requirements. All serum is collected from calves aged 10 days old or less....
Biology Products: